News

Biophysicists have used supercomputers to show how cell membranes control the shape, and consequently the function, of a major cancer-causing protein.

Immunotherapy drug avelumab (Bavencio®) has been given the green light for some patients with Merkel cell carcinoma.

Study finds that tumor blood vessels and the immune system influence each other’s functions, and propose that considering these bilateral effects in cancer therapy might improve outcomes.

Preclinical study demonstrates the use of nanoparticles to improve the efficacy of immunotherapy drugs known as checkpoint inhibitors.

The microfluidic device could offer a less invasive way of diagnosing and monitoring multiple myeloma than current bone marrow biopsies.

Research team injected tumors with an experimental drug based on a certain bacterial molecule that triggers a powerful immune response.

The new blood tests take only 48 hours to complete, and reliably identify melanoma DNA in a patient's blood.

The length of the telomere “caps” of DNA that protect the tips of chromosomes may predict cancer risk and be a potential target for future therapeutics.

Findings make it possible to distinguish poorly invasive tumors from those that will likely spread and metastasize.

CRISPR-based system quickly screens non-coding genome for regulatory elements of disease genes.